Yudy Fonseca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yudy Fonseca has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adnan T. Bhutta
University of Arkansas Medical Center
1 shared publication - Adnan T. Mbbs Bhutta
Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine/Riley Children’s Health, Indianapolis, IN
1 shared publication - Alise Pa Davies
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication - Cortney B. Foster
Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland, Baltimore, MD
1 shared publication Evangelina Urbina
Hospitalidad de Especialidades Pediatricas, Tuxtla Gutierrez, Chiapas, Mexico; University of Maryland Medical Center, MD, Baltimore
1 shared publicationGavin Wooldridge
Pediatric Intensive Care, BC Children's Hospital, Vancouver, Canada
1 shared publication
Latest Publications
- Open Access
- 15 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1206
Prevalence of Pulmonary Embolism in COVID-19 Positive Critically Ill Children
OBJECTIVES: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection. DESIGN: Retrospective database study. SETTING: Data reported to the Virtual Pediatric Systems, 2018–2021. PATIENTS: Patients 28 days to younger than 18 years old, admitted to a PICU with either PE or COVID-19 diagnoses. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the PE-positive subgroups, from January 2020 to December 2021, 78 patients (14%) had an acute COVID-19 infection. The prevalence of PE pre-pandemic period (2018–2019) was 0.19% and for pandemic period (2020–2021) was 0.26% (p < 0.001). During the pandemic period, the prevalence of PE for COVID-negative patients was 0.21% and for COVID-positive patients was 1.01% (p < 0.001). The result shows that the chance to develop PE for COVID-positive patients is 4.8 times that for COVID-negative patients during the pandemic. In the subgroup of the PE-positive patients, 55.1% were Black or African American in the COVID-positive group and 19% in the COVID-negative group (p < 0.001). A multivariable logistic regression showed that race was an independent risk factor for COVID in PE-positive patients. CONCLUSIONS: Our study demonstrates a significant increase in the prevalence of PE among pediatric patients admitted to PICUs during the COVID-19 pandemic compared with pre-pandemic. Our study indicates that COVID-positive patients are 4.8 times more likely to develop PE than COVID-negative patients. Additionally, the study highlights substantial racial disparities in the prevalence of PE, with Black or African American patients being disproportionately affected.
- 15 January 2025
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (1) , e1206
Open AccessPrevalence of Pulmonary Embolism in COVID-19 Positive Critically Ill Children
OBJECTIVES: To investigate the prevalence of pulmonary embolism (PE) in children admitted to critical care diagnosed with COVID-19 infection. DESIGN: Retrospective database study. SETTING: Data reported to the Virtual Pediatric Systems, 2018–2021. PATIENTS: Patients 28 days to younger than 18 years old, admitted to a PICU with either PE or COVID-19 diagnoses. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the PE-positive subgroups, from January 2020 to December 2021, 78 patients (14%) had an acute COVID-19 infection. The prevalence of PE pre-pandemic period (2018–2019) was 0.19% and for pandemic period (2020–2021) was 0.26% (p < 0.001). During the pandemic period, the prevalence of PE for COVID-negative patients was 0.21% and for COVID-positive patients was 1.01% (p < 0.001). The result shows that the chance to develop PE for COVID-positive patients is 4.8 times that for COVID-negative patients during the pandemic. In the subgroup of the PE-positive patients, 55.1% were Black or African American in the COVID-positive group and 19% in the COVID-negative group (p < 0.001). A multivariable logistic regression showed that race was an independent risk factor for COVID in PE-positive patients. CONCLUSIONS: Our study demonstrates a significant increase in the prevalence of PE among pediatric patients admitted to PICUs during the COVID-19 pandemic compared with pre-pandemic. Our study indicates that COVID-positive patients are 4.8 times more likely to develop PE than COVID-negative patients. Additionally, the study highlights substantial racial disparities in the prevalence of PE, with Black or African American patients being disproportionately affected.
- Open Access
- 11 October 2022
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 13 (3) , 1465-14
Expanding current guidelines for management of COVID-19 focusing on low- and middle-income countries
Within a short time, Coronavirus disease 2019 (COVID-19) has evolved into a pandemic spreading at a speed and scale that has been able to overwhelm even the most advanced healthcare systems quickly. Multiple guidelines published by organizations such as the WHO and US’ CDC address the response to COVID-19 at the international, national, and local levels. Although these guidelines are meant to be globally accessible, implementing them is a challenge given the variability in the health care systems worldwide between low- and middle-income countries (LMIC) and high-income countries and even amongst different regions within each LMIC. We have chosen to evaluate the current guidelines focusing on LMIC and expand on the guidelines as necessary.
- 11 October 2022
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 13 (3) , 1465-14
Open AccessExpanding current guidelines for management of COVID-19 focusing on low- and middle-income countries
Within a short time, Coronavirus disease 2019 (COVID-19) has evolved into a pandemic spreading at a speed and scale that has been able to overwhelm even the most advanced healthcare systems quickly. Multiple guidelines published by organizations such as the WHO and US’ CDC address the response to COVID-19 at the international, national, and local levels. Although these guidelines are meant to be globally accessible, implementing them is a challenge given the variability in the health care systems worldwide between low- and middle-income countries (LMIC) and high-income countries and even amongst different regions within each LMIC. We have chosen to evaluate the current guidelines focusing on LMIC and expand on the guidelines as necessary.
- 1 October 2020
- Published by Elsevier in Pediatric Neurology
- Vol. 111, 85-86
Confirming Pediatric Brain Death in Resource-Limited Settings: Lessons and Challenges
- 1 October 2020
- Published by Elsevier in Pediatric Neurology
- Vol. 111, 85-86
Confirming Pediatric Brain Death in Resource-Limited Settings: Lessons and Challenges